These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 23904396)

  • 1. Epicardial adipose tissue predicts mortality in incident hemodialysis patients: a substudy of the Renagel in New Dialysis trial.
    D'Marco LG; Bellasi A; Kim S; Chen Z; Block GA; Raggi P
    Nephrol Dial Transplant; 2013 Oct; 28(10):2586-95. PubMed ID: 23904396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epicardial adipose tissue volume increase in hemodialysis patients treated with sevelamer or calcium-based phosphate binders: a substudy of the Renagel in new dialysis trial.
    Ko SM; Zhang C; Chen Z; D'Marco L; Bellasi A; Stillman AE; Block G; Raggi P
    J Nephrol; 2016 Oct; 29(5):683-90. PubMed ID: 27102490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mortality effect of coronary calcification and phosphate binder choice in incident hemodialysis patients.
    Block GA; Raggi P; Bellasi A; Kooienga L; Spiegel DM
    Kidney Int; 2007 Mar; 71(5):438-41. PubMed ID: 17200680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sevelamer versus calcium carbonate in incident hemodialysis patients: results of an open-label 24-month randomized clinical trial.
    Di Iorio B; Molony D; Bell C; Cucciniello E; Bellizzi V; Russo D; Bellasi A;
    Am J Kidney Dis; 2013 Oct; 62(4):771-8. PubMed ID: 23684755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of sevelamer and calcium-based phosphate binders on coronary artery calcification and accumulation of circulating advanced glycation end products in hemodialysis patients.
    Kakuta T; Tanaka R; Hyodo T; Suzuki H; Kanai G; Nagaoka M; Takahashi H; Hirawa N; Oogushi Y; Miyata T; Kobayashi H; Fukagawa M; Saito A
    Am J Kidney Dis; 2011 Mar; 57(3):422-31. PubMed ID: 21239096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A 1-year randomized trial of calcium acetate versus sevelamer on progression of coronary artery calcification in hemodialysis patients with comparable lipid control: the Calcium Acetate Renagel Evaluation-2 (CARE-2) study.
    Qunibi W; Moustafa M; Muenz LR; He DY; Kessler PD; Diaz-Buxo JA; Budoff M;
    Am J Kidney Dis; 2008 Jun; 51(6):952-65. PubMed ID: 18423809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epicardial adipose tissue and coronary artery calcium predict incident myocardial infarction and death in HIV-infected patients.
    Raggi P; Zona S; Scaglioni R; Stentarelli C; Ligabue G; Besutti G; Menozzi M; Santoro A; Malagoli A; Bellasi A; Guaraldi G
    J Cardiovasc Comput Tomogr; 2015; 9(6):553-8. PubMed ID: 26310588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epicardial adipose tissue in long-term hemodialysis patients: its association with vascular calcification and long-term development.
    Barros X; Dirrichs T; Koos R; Reinartz S; Kaesler N; Kramann R; Gladziwa U; Ketteler M; Floege J; Marx N; Torregrosa JV; Keszei A; Brandenburg VM
    J Nephrol; 2016 Apr; 29(2):241-250. PubMed ID: 26253562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serological cardiovascular and mortality risk predictors in dialysis patients receiving sevelamer: a prospective study.
    Brandenburg VM; Schlieper G; Heussen N; Holzmann S; Busch B; Evenepoel P; Vanholder R; Meijers B; Meert N; Fassbender WJ; Floege J; Jahnen-Dechent W; Ketteler M
    Nephrol Dial Transplant; 2010 Aug; 25(8):2672-9. PubMed ID: 20172849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Persistent epicardial adipose tissue accumulation is associated with coronary plaque vulnerability and future acute coronary syndrome in non-obese subjects with coronary artery disease.
    Nakanishi K; Fukuda S; Tanaka A; Otsuka K; Jissho S; Taguchi H; Yoshikawa J; Shimada K
    Atherosclerosis; 2014 Nov; 237(1):353-60. PubMed ID: 25310459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ten-year experience with sevelamer and calcium salts as phosphate binders.
    Raggi P; Vukicevic S; Moysés RM; Wesseling K; Spiegel DM
    Clin J Am Soc Nephrol; 2010 Jan; 5 Suppl 1():S31-40. PubMed ID: 20089501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between epicardial adipose tissue, inflammation and volume markers in hemodialysis and transplant patients.
    Çolak H; Kilicarslan B; Tekce H; Tanrisev M; Tugmen C; Aktas G; Kursat S
    Ther Apher Dial; 2015 Feb; 19(1):56-62. PubMed ID: 25628169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors associated with mortality in patients new to haemodialysis.
    Spiegel DM; Raggi P; Smits G; Block GA
    Nephrol Dial Transplant; 2007 Dec; 22(12):3568-72. PubMed ID: 17617651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of sevelamer and calcium-based phosphate binders on mortality in hemodialysis patients: results of a randomized clinical trial.
    Suki WN;
    J Ren Nutr; 2008 Jan; 18(1):91-8. PubMed ID: 18089452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distribution of coronary artery disease and relation to mortality in asymptomatic hemodialysis patients.
    Charytan D; Kuntz RE; Mauri L; DeFilippi C
    Am J Kidney Dis; 2007 Mar; 49(3):409-16. PubMed ID: 17336702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of intensive versus moderate lipid-lowering therapy on epicardial adipose tissue in hyperlipidemic post-menopausal women: a substudy of the BELLES trial (Beyond Endorsed Lipid Lowering with EBT Scanning).
    Alexopoulos N; Melek BH; Arepalli CD; Hartlage GR; Chen Z; Kim S; Stillman AE; Raggi P
    J Am Coll Cardiol; 2013 May; 61(19):1956-61. PubMed ID: 23500254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of efficacy of the phosphate binders nicotinic acid and sevelamer hydrochloride in hemodialysis patients.
    Ahmadi F; Shamekhi F; Lessan-Pezeshki M; Khatami MR
    Saudi J Kidney Dis Transpl; 2012 Sep; 23(5):934-8. PubMed ID: 22982903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating vascular endothelial growth factor (VEGF) and its soluble receptor 1 (sVEGFR-1) are associated with inflammation and mortality in incident dialysis patients.
    Yuan J; Guo Q; Qureshi AR; Anderstam B; Eriksson M; Heimbürger O; Bárány P; Stenvinkel P; Lindholm B
    Nephrol Dial Transplant; 2013 Sep; 28(9):2356-63. PubMed ID: 23828162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mortality in kidney disease patients treated with phosphate binders: a randomized study.
    Di Iorio B; Bellasi A; Russo D;
    Clin J Am Soc Nephrol; 2012 Mar; 7(3):487-93. PubMed ID: 22241819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased epicardial adipose tissue is associated with coronary artery disease and major adverse cardiovascular events.
    Hajsadeghi F; Nabavi V; Bhandari A; Choi A; Vincent H; Flores F; Budoff M; Ahmadi N
    Atherosclerosis; 2014 Dec; 237(2):486-9. PubMed ID: 25463078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.